D
CRISPR Therapeutics AG CRSP
$41.86 $3.298.53% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue 37.68M 37.31M 202.83M 202.23M 271.71M
Total Other Revenue -- -- -- -- --
Total Revenue 37.68M 37.31M 202.83M 202.23M 271.71M
Cost of Revenue 437.76M 430.90M 463.89M 484.70M 498.59M
Gross Profit -400.08M -393.59M -261.06M -282.47M -226.88M
SG&A Expenses 74.32M 72.98M 71.33M 72.20M 71.76M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 512.08M 503.88M 535.22M 556.90M 570.35M
Operating Income -474.40M -466.57M -332.39M -354.68M -298.64M
Income Before Tax -381.69M -362.67M -236.47M -263.15M -214.84M
Income Tax Expenses 3.97M 3.59M 3.12M 2.66M 2.29M
Earnings from Continuing Operations -385.66 -366.25 -239.59 -265.80 -217.14
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -385.66M -366.25M -239.59M -265.80M -217.14M
EBIT -474.40M -466.57M -332.39M -354.68M -298.64M
EBITDA -455.24M -447.31M -313.08M -335.17M -279.02M
EPS Basic -4.52 -4.36 -2.80 -3.20 -2.70
Normalized Basic EPS -2.79 -2.70 -1.73 -1.98 -1.67
EPS Diluted -4.52 -4.37 -2.84 -3.24 -2.73
Normalized Diluted EPS -2.79 -2.70 -1.74 -2.00 -1.68
Average Basic Shares Outstanding 341.56M 337.41M 331.64M 325.82M 319.99M
Average Diluted Shares Outstanding 341.56M 337.41M 333.28M 327.45M 321.62M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --